L-Arginine Improves Cognitive Impairment in Hypertensive Frail Older Adults.
- 2022-04-12
- Clinical Trial
- Frontiers in cardiovascular medicine 9
- Pasquale Mone
- Antonella Pansini
- Stanislovas S Jankauskas
- Fahimeh Varzideh
- Urna Kansakar
- Angela Lombardi
- Valentina Trimarco
- Salvatore Frullone
- Gaetano Santulli
- PubMed: 35498050
- DOI: 10.3389/fcvm.2022.868521
- High evidence
- Clinical
At follow-up, we found a significant difference in the Montreal Cognitive Assessment (MoCA) test score between the L-Arginine treated group and placebo (p: 0.0178).
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes